• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr. Kolodziej Discusses Personalized Medicine in Oncology

Article

Michael Kolodziej, MD, National Medical Director for Oncology Strategies, Aetna, says that the rapid emergence of precision medicine was one of the more interesting topics discussed at the ASCO 2013 Annual Meeting.

Michael Kolodziej, MD, National Medical Director for Oncology Strategies, Aetna, says that the rapid emergence of precision medicine was one of the more interesting topics discussed at the ASCO 2013 Annual Meeting. Dr Kolodziej discussed the importance of understanding how the information on specific genetic mutations to tailor therapy that is optimal for each patient will be used. "I think the discussion about how to develop the necessary quantum of information that you need to prove that it actually works," said Dr Kolodziej "Because from a payer perspective clinical utility is going to be the most important thing."

This video was taken on June 1, 2013, at the ASCO Annual Meeting 2013 in Chicago, IL.

Related Videos
Ivo Carre, PhD, senior business analyst, Lifescience Dynamics
Drs Yelena Janjigian and Zev Wainberg | Background image credit: ipopba - stock.adobe.com
Nicoletta Colombo, MD, PhD
AHA 2025 recap layered on photo of Bourbon Street in New Orleans | Image credit: SeanPavonePhoto - stock.adobe.com
Screenshot of an interview with Stephen Nicholls, MBBS, PhD
Screenshot of an interview with Roy Mathew, MD
Screenshot of an interview with Vallerie McLaughlin, MD
Oncology experts at PCOC
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.